Tuberculosis Professional Committee of Chinese Research Hospital Association,
Email: blueske_520@163.com
The significant increase in mortality after tuberculosis (TB) progression to severe disease is a major obstacle to achieving the goal of ending the TB epidemic by 2035. Up to now, there is no clear definition and diagnostic criteria for adult severe tuberculosis at home or abroad, which has a significant adverse impact on the early diagnosis and timely treatment of patients with severe tuberculosis. In order to improve the treatment level of patients with severe pulmonary tuberculosis, reduce mortality and improve prognosis. The Professional Committee of Tuberculosis Science of the Chinese Society of Research Hospitals and Shenzhen Third People's Hospital/National Clinical Medical Research Center of Infectious Diseases/Shenzhen Tuberculosis Clinical Medical Research Center led the formulation of "Guidelines for definition and diagnosis of severe pulmonary tuberculosis in adults in China (2023)", aiming to guide and standardize the definition and diagnosis of severe tuberculosis. So as to improve the level of diagnosis and treatment of severe pulmonary tuberculosis in our country, to maximize the benefit of patients.
| 1. | WHO. Global tuberculosis report 2023. 2023. |
| 2. | 毛敏杰, 汪彩红, 潘蕾. 细胞免疫和体液免疫功能检测对重症结核病患者的临床意义. 中华危重症医学杂志(电子版), 2015, 8(2): 109-111. |
| 3. | Duro RP, Figueiredo Dias P, Ferreira AA, et al. Severe tuberculosis requiring intensive care: a descriptive analysis. Crit Care Res Pract, 2017, 2017: 9535463. |
| 4. | 刘同伦. 实用结核病学. 沈阳: 辽宁科学技术出版社, 1987: 284-289. |
| 5. | 苏瑾文. 重症肺结核学免疫特性研究. 北京: 中国人民解放军医学院, 2015. |
| 6. | Kim CW, Kim SH, Lee SN, et al. Risk factors related with mortality in patient with pulmonary tuberculosis. Tuberc Respir Dis (Seoul), 2012, 73(1): 38-47. |
| 7. | Loh WJ, Yu Y, Loo CM, et al. Factors associated with mortality among patients with active pulmonary tuberculosis requiring intensive care. Singapore Med J, 2017, 58(11): 656-659. |
| 8. | WHO. WHO handbook for guideline development (2nd ed). Vienna: World Health Organization, 2014. |
| 9. | Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): 839-842. |
| 10. | Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132. |
| 11. | Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 2017, 358: j4008. |
| 12. | Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ, 2011, 343: d5928. |
| 13. | Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med, 2011, 155(8): 529-536. |
| 14. | Wells GA, Shea BJ, O'Connell D, et al. The Newcastle‐Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta‐analyses. 2011. |
| 15. | Moga C, Guo B, Schopflocher D, et al. Development of a quality appraisal tool for case series studies using a modified Delphi technique. 2012. |
| 16. | OCEBM Levels of Evidence Working Group. OCEBM levels of evidence. 2009. |
| 17. | 李纯. 分析重症肺结核合并呼吸衰竭的临床特征. 中国医药指南, 2019, 17(24): 51. |
| 18. | 刘丽, 闫佩英. 重症肺结核合并呼吸衰竭的临床治疗体会. 世界最新医学信息文摘(连续型电子期刊), 2019, 19(38): 89-90. |
| 19. | 刘国波. 重症肺结核合并呼吸衰竭的临床护理. 中国医药指南, 2019, 17(1): 183-184. |
| 20. | 刘晓宁, 李晔. 青年重症肺结核的临床特点及其影响因素分析. 临床肺科杂志, 2020, 25(9): 1419-1423. |
| 21. | 刘丹. 重症肺结核合并呼吸衰竭的临床护理. 饮食科学, 2017, (20): 1. |
| 22. | 苏瑾文, 刘艳华, 杨秉芬, 等. 重症继发性肺结核患者差异表达基因和IL-1β表达的验证. 中华临床医师杂志(电子版), 2014, (23): 4186-4190. |
| 23. | 苏瑾文, 刘艳华, 杨秉芬, 等. CCL3、CCL4下调表达和重症继发性肺结核病理损伤的关系. 山西医科大学学报, 2015, 46(4): 300-304. |
| 24. | 王译, 陆利欢, 陈建. 重症活动性肺结核患者凝血功能变化的临床分析. 临床医药文献电子杂志, 2020, 7(13): 27-28. |
| 25. | 鲁进, 黄汉平. 重症肺结核病合并类白血病反应误诊分析报告1例. 中国医药科学, 2017, 7(18): 254-256. |
| 26. | 唐理斌, 李海雯. 经鼻高流量氧疗与无创机械通气在重症肺结核合并呼吸衰竭中的疗效对比研究. 健康必读, 2019, (33): 23. |
| 27. | 戚世钦, 杨荣, 吴春玲. 含卷曲霉素化疗方案联合胸腺五肽和复方氨基酸双肽治疗重症肺结核的临床疗效分析. 现代诊断与治疗, 2016, 27(8): 1431-1433. |
| 28. | 国家卫生和计划生育委员会. 肺结核诊断标准(WS 288-2017). 2017. |
| 29. | WHO. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: module 1: prevention. 2020. |
| 30. | 蔡静, 汪求真, 韩秀霞, 等. 肺结核患者就诊临床表现及变化特点调查分析. 中华疾病控制杂志, 2012, 16(5): 417-420. |
| 31. | 李文君, 王玲, 曾令玉, 等. 72例涂阳肺结核患者临床特点分析. 新疆医学, 2018, 48(1): 47-50. |
| 32. | 张力英, 李琦, 王苹, 等. 慢性阻塞性肺疾病合并肺性脑病的临床特征及其危险因素分析. 中华肺部疾病杂志(电子版), 2021, 14(4): 530-532. |
| 33. | 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版). 中华结核和呼吸杂志, 2016, 39(4): 253-279. |
| 34. | 张虹. 优质护理用于重症结核合并糖尿病的临床护理效果分析. 糖尿病新世界, 2018, 21(21): 131-132. |
| 35. | 陈娟, 毛毅, 陈洪德. 30例危重症肺结核孕产妇的临床特征及预后分析. 中国防痨杂志, 2020, 42(6): 638-640. |
| 36. | 刘燕侠. 肺结核合并肝性脑病34例护理体会. 中国实用神经疾病杂志, 2015, 18(13): 122. |
| 37. | 张亚敬, 姜影, 孙浩, 等. 154例老年肺结核患者的发现与治疗转归情况分析. 结核与肺部疾病杂志, 2023, 4(1): 48-53. |
| 38. | 朱丽雅. 重症肺结核合并呼吸衰竭的护理. 中国基层医药, 2013, 20(2): 296-297. |
| 39. | 谢朝云, 覃家露, 熊芸, 等. 重症肺结核患者死亡危险因素分析. 人民军医, 2018, 61(1): 30-33, 37. |
| 40. | 冀小波, 毛敏杰, 徐节坤, 等. 重症肺结核合并真菌感染患者的临床特征及发病危险因素分析. 浙江医学, 2021, 43(18): 2013-2016, 2019. |
| 41. | 中华医学会结核病学分会重症专业委员会. 结核病营养治疗专家共识. 中华结核和呼吸杂志, 2020, 43(1): 17-26. |
| 42. | 张楠, 李琦, 潘丽萍, 等. 结核重症监护室真菌感染的危险因素分析. 中国医药导报, 2019, 16(1): 74-76, 81. |
| 43. | 王红岩, 张昕. 结核重症监护室呼吸机相关性肺炎感染的危险因素分析. 中国医药指南, 2020, 18(6): 108-109. |
| 44. | 王红岩, 张昕. 重症肺结核合并呼吸衰竭的临床特征分析. 中国医药指南, 2020, 18(16): 130-131. |
| 45. | 万青梅. 重症肺结核合并呼吸衰竭患者的临床护理方法以及效果评价. 医学美学美容(中旬刊), 2014, 23(8): 366. |
| 46. | 疏欣杨, 唐亮, 孙兵. 呼吸重症监护病房中以呼吸衰竭为突出表现的肺结核临床特点. 中日友好医院学报, 2014, 28(3): 139-142, 封2. |
| 47. | 石丽彩, 杨桂梅. 重症肺结核合并呼吸衰竭患者的护理. 临床合理用药杂志, 2012, 5(29): 166. |
| 48. | 马增光, 李志军, 陈杰勇. 重症肺结核79例临床分析. 临床合理用药杂志, 2014, 7(25): 39. |
| 49. | 李先锋. 青年重症肺结核60例观察与治疗. 医药前沿, 2014, (8): 115-116. |
| 50. | 李红. 重症肺结核合并呼吸衰竭临床分析. 中国卫生标准管理, 2015, 6(12): 132-133. |
| 51. | 李海涛, 郭晓新. 初治重症肺结核发现延迟相关因素分析. 河南预防医学杂志, 2012, 23(4): 275-276. |
| 52. | 龚惠莉. 60例重症肺结核合并呼吸衰竭临床分析. 现代预防医学, 2012, 39(1): 248-249. |
| 53. | 刘岩, 丁龙. 30例重症肺结核回顾性影像分析. 健康必读旬刊, 2013, 12(11): 101. |
| 54. | Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med, 1995, 23(10): 1638-1652. |
| 55. | 中华医学会结核病学分会. 肺结核诊断和治疗指南. 中国实用乡村医生杂志, 2013, 20(2): 7-11. |
| 56. | Telisinghe L, Fielding KL, Malden JL, et al. High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PLoS One, 2014, 9(1): e87262. |
| 57. | Nguyen TBP, Nguyen TA, Luu BK, et al. A comparison of digital chest radiography and Xpert® MTB/RIF in active case finding for tuberculosis. Int J Tuberc Lung Dis, 2020, 24(9): 934-940. |
| 58. | 中华医学会放射学分会传染病放射学专业委员会. 肺结核影像学及分级诊断专家共识. 新发传染病电子杂志, 2018, 3(2): 118-127. |
| 59. | 刘长春, 古海尔, 常银勇, 等. 重症肺结核CT影像分析. 临床肺科杂志, 2007, 12(12): 1302-1304. |
| 60. | 陈影. 老年肺结核临床分析. 中国实用医药, 2015, (15): 61-62. |
| 61. | 周伟剑. 艾滋病患者合并重症肺结核的X线表现的探讨. 现代医用影像学, 2015, 24(6): 902-904. |
| 62. | 李宁, 王晓静, 冯光, 等. 高能量营养乳剂的肠内营养对重症肺结核机械通气患者的临床疗效. 临床肺科杂志, 2013, 18(5): 780-782. |
| 63. | Shaarawy H, El-Sayed Mohamed E. Assessment of the prevalence of pulmonary embolism in patients with severe pulmonary tuberculosis. Egypt J Chest Dis Tuberc, 2018, 67(1): 62-67. |
| 64. | 中华人民共和国国家卫生和计划生育委员会. 结核病分类(WS196—2017). 新发传染病电子杂志, 2018, 3(3): 191-192. |
| 65. | Pai M, Schito M. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis, 2015, 211(Suppl 2): S21-S28. |
| 66. | 《中国防痨杂志》编辑委员会, 中国医疗保健国际交流促进会结核病防治分会基础学组和临床学组. 结核分枝杆菌耐药性检测专家共识. 中国防痨杂志, 2019, 41(2): 129-137. |
| 67. | 中华医学会结核病学分会临床检验专业委员会. 结核病病原学分子诊断专家共识. 中华结核和呼吸杂志, 2018, 41(9): 688-695. |
| 68. | 刘一典. 复治肺结核病诊断和治疗专家共识. 中国防痨杂志, 2021, 43(12): 1226-1238. |
| 69. | Fusani L, Tersigni C, Chiappini E, et al. Old biomarkers in tuberculosis management: are they still useful. A systematic review. Expert Rev Anti Infect Ther, 2021, 19(10): 1191-1203. |
| 70. | Pierce R, Bigham MT, Giuliano JS. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children. Curr Opin Pediatr, 2014, 26(3): 292-298. |
| 71. | Kamat IS, Ramachandran V, Eswaran H, et al. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis, 2020, 70(3): 538-542. |
| 72. | Martin-Loeches I, Torres A, Nagavci B, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J, 2023, 61(4): 2200735. |
| 73. | Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med, 2008, 177(5): 498-505. |
| 74. | 李成行, 李月翠. 检测内毒素与C反应蛋白在诊断肺结核合并革兰阴性菌感染中的意义. 中国防痨杂志, 2013, 35(9): 702-705. |
| 75. | 万学红, 卢雪峰. 诊断学(第9版). 北京: 人民卫生出版社, 2018: 409-442. |
| 76. | Jones BE, Oo MM, Taikwel EK, et al. CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis, 1997, 24(5): 988-991. |
| 77. | 俞朝贤, 李德宪, 王娟, 等. 结核重症监护室患者外周血CD4+T淋巴细胞的检测与临床意义. 现代医院, 2019, 19(7): 1084-1086. |
| 78. | 汪彩红, 邱君克, 黄晓庆, 等. 重症肺结核患者外周血T细胞亚群在预后不良患者中的表达及临床意义. 中华医院感染学杂志, 2020, 30(9): 1327-1330. |
| 79. | 卫芳征. 外周血T细胞亚群和红细胞免疫功能与重症肺结核患者不良预后的相关性. 临床肺科杂志, 2018, 23(9): 1561-1565. |
| 80. | 黄健, 李明瑛, 牛文一, 等. 外周血Blimp1、IFN-γ、IL-10水平与重症肺结核的相关性分析. 分子诊断与治疗杂志, 2020, 12(12): 1745-1748. |
| 81. | 章敏. 外周血IFN-γ、IL-10水平及红细胞免疫功能对重症肺结核患者死亡预后的预测价值. 标记免疫分析与临床, 2020, 27(7): 1161-1165. |
| 82. | Kho ME, McDonald E, Stratford PW, et al. Interrater reliability of APACHE Ⅱ scores for medical surgical intensive care patients: a prospect blinded study. Am J Crit Care, 2007, 16: 378-380. |
| 83. | Lambden S, Laterre PF, Levy MM, et al. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care, 2019, 23(1): 374. |
| 84. | 王超, 苏强, 张淑文, 等. 多器官功能障碍综合征病情严重度评分系统. 中国医学科学院学报, 2007, 29(4): 497-500. |
| 85. | Wang D, Willis DR, Yih Y. The pneumonia severity index: assessment and comparison to popular machine learning classifiers. Int J Med Inform, 2022, 163: 104778. |
| 86. | 李宁, 王晓静, 冯光, 等. 重症肺结核合并COPD患者机械通气死亡预后因素分析. 临床肺科杂志, 2013, 18(4): 711-712. |
| 87. | Tatar D, Senol G, Kirakli C, et al. Contributing factors to mortality rates of pulmonary tuberculosis in intensive care units. J Chin Med Assoc, 2018, 81(7): 605-610. |
| 88. | Galvin J, Tiberi S, Akkerman O, et al. Pulmonary tuberculosis in intensive care setting, with a focus on the use of severity scores, a multinational collaborative systematic review. Pulmonology, 2022, 28(4): 297-309. |
| 89. | Rollas K, Kara A, Ortaç Ersoy NE, et al. Acute tuberculosis in the intensive care unit. Turk J Med Sci, 2015, 45(4): 882-887. |
| 90. | 张如云, 张静, 雷轩. 血清白蛋白、SOFA评分及APACHEⅡ评分对重症肺结核患者预后的评估价值. 临床肺科杂志, 2023, 28(3): 399-401,411. |
| 91. | Kim S, Kim H, Kim WJ, et al. Mortality and predictors in pulmonary tuberculosis with respiratory failure requiring mechanical ventilation. Int J Tuberc Lung Dis, 2016, 20(4): 524-529. |
| 92. | Cegielski JP, Arab L, Cornoni-Huntley J. Nutritional risk factors for tuberculosis among adults in the United States, 1971-1992. Am J Epidemiol, 2012, 176(5): 409-422. |
| 93. | WHO. WHO guidelines approved by the guidelines review committee. 2013. |
| 94. | Mueller C, Compher C, Ellen DM, et al. A. S. P. E. N. clinical guidelines: nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr, 2011, 35(1): 16-24. |
| 95. | Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr, 2003, 22(3): 321-336. |
| 96. | Heyland DK, Dhaliwal R, Jiang X, et al. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care, 2011, 15(6): R268. |
| 97. | 章志俊, 谭守勇. 营养风险筛查在结核病治疗中应用. 中国防痨杂志, 2015, 37(9): 971-974. |
| 98. | 营养风险及营养支持调查协作组, 蒋朱明, 陈伟, 等. 中国东、中、西部大城市三甲医院营养不良(不足)、营养风险发生率及营养支持应用状况调查. 中国临床营养杂志, 2008, 16(6): 335-337. |
| 99. | 顾良军, 詹斯·康卓普, 雷米·梅耶, 等. 营养风险筛查2002改善临床结局. 中华临床营养杂志, 2013, 21(3): 133-139. |
| 100. | Felder S, Lechtenboehmer C, Bally M, et al. Association of nutritional risk and adverse medical outcomes across different medical inpatient populations. Nutrition, 2015, 31(11-12): 1385-1393. |
| 101. | Mukhopadhyay A, Henry J, Ong V, et al. Association of modified NUTRIC score with 28-day mortality in critically ill patients. Clin Nutr, 2017, 36(4): 1143-1148. |
| 102. | Canales C, Elsayes A, Yeh DD, et al. Nutrition risk in critically ill versus the nutritional risk screening 2002: are they comparable for assessing risk of malnutrition in critically ill patients. JPEN J Parenter Enteral Nutr, 2019, 43(1): 81-87. |
| 103. | Heyland DK, Dhaliwal R, Wang M, et al. The prevalence of iatrogenic underfeeding in the nutritionally 'at-risk' critically ill patient: results of an international, multicenter, prospective study. Clin Nutr, 2015, 34(4): 659-666. |
| 104. | 陈志, 梁建琴. 结核病重症患者营养评估及营养支持治疗专家共识. 中国防痨杂志, 2022, 44(5): 421-432. |
- 1. WHO. Global tuberculosis report 2023. 2023.
- 2. 毛敏杰, 汪彩红, 潘蕾. 细胞免疫和体液免疫功能检测对重症结核病患者的临床意义. 中华危重症医学杂志(电子版), 2015, 8(2): 109-111.
- 3. Duro RP, Figueiredo Dias P, Ferreira AA, et al. Severe tuberculosis requiring intensive care: a descriptive analysis. Crit Care Res Pract, 2017, 2017: 9535463.
- 4. 刘同伦. 实用结核病学. 沈阳: 辽宁科学技术出版社, 1987: 284-289.
- 5. 苏瑾文. 重症肺结核学免疫特性研究. 北京: 中国人民解放军医学院, 2015.
- 6. Kim CW, Kim SH, Lee SN, et al. Risk factors related with mortality in patient with pulmonary tuberculosis. Tuberc Respir Dis (Seoul), 2012, 73(1): 38-47.
- 7. Loh WJ, Yu Y, Loo CM, et al. Factors associated with mortality among patients with active pulmonary tuberculosis requiring intensive care. Singapore Med J, 2017, 58(11): 656-659.
- 8. WHO. WHO handbook for guideline development (2nd ed). Vienna: World Health Organization, 2014.
- 9. Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): 839-842.
- 10. Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132.
- 11. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 2017, 358: j4008.
- 12. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ, 2011, 343: d5928.
- 13. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med, 2011, 155(8): 529-536.
- 14. Wells GA, Shea BJ, O'Connell D, et al. The Newcastle‐Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta‐analyses. 2011.
- 15. Moga C, Guo B, Schopflocher D, et al. Development of a quality appraisal tool for case series studies using a modified Delphi technique. 2012.
- 16. OCEBM Levels of Evidence Working Group. OCEBM levels of evidence. 2009.
- 17. 李纯. 分析重症肺结核合并呼吸衰竭的临床特征. 中国医药指南, 2019, 17(24): 51.
- 18. 刘丽, 闫佩英. 重症肺结核合并呼吸衰竭的临床治疗体会. 世界最新医学信息文摘(连续型电子期刊), 2019, 19(38): 89-90.
- 19. 刘国波. 重症肺结核合并呼吸衰竭的临床护理. 中国医药指南, 2019, 17(1): 183-184.
- 20. 刘晓宁, 李晔. 青年重症肺结核的临床特点及其影响因素分析. 临床肺科杂志, 2020, 25(9): 1419-1423.
- 21. 刘丹. 重症肺结核合并呼吸衰竭的临床护理. 饮食科学, 2017, (20): 1.
- 22. 苏瑾文, 刘艳华, 杨秉芬, 等. 重症继发性肺结核患者差异表达基因和IL-1β表达的验证. 中华临床医师杂志(电子版), 2014, (23): 4186-4190.
- 23. 苏瑾文, 刘艳华, 杨秉芬, 等. CCL3、CCL4下调表达和重症继发性肺结核病理损伤的关系. 山西医科大学学报, 2015, 46(4): 300-304.
- 24. 王译, 陆利欢, 陈建. 重症活动性肺结核患者凝血功能变化的临床分析. 临床医药文献电子杂志, 2020, 7(13): 27-28.
- 25. 鲁进, 黄汉平. 重症肺结核病合并类白血病反应误诊分析报告1例. 中国医药科学, 2017, 7(18): 254-256.
- 26. 唐理斌, 李海雯. 经鼻高流量氧疗与无创机械通气在重症肺结核合并呼吸衰竭中的疗效对比研究. 健康必读, 2019, (33): 23.
- 27. 戚世钦, 杨荣, 吴春玲. 含卷曲霉素化疗方案联合胸腺五肽和复方氨基酸双肽治疗重症肺结核的临床疗效分析. 现代诊断与治疗, 2016, 27(8): 1431-1433.
- 28. 国家卫生和计划生育委员会. 肺结核诊断标准(WS 288-2017). 2017.
- 29. WHO. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: module 1: prevention. 2020.
- 30. 蔡静, 汪求真, 韩秀霞, 等. 肺结核患者就诊临床表现及变化特点调查分析. 中华疾病控制杂志, 2012, 16(5): 417-420.
- 31. 李文君, 王玲, 曾令玉, 等. 72例涂阳肺结核患者临床特点分析. 新疆医学, 2018, 48(1): 47-50.
- 32. 张力英, 李琦, 王苹, 等. 慢性阻塞性肺疾病合并肺性脑病的临床特征及其危险因素分析. 中华肺部疾病杂志(电子版), 2021, 14(4): 530-532.
- 33. 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版). 中华结核和呼吸杂志, 2016, 39(4): 253-279.
- 34. 张虹. 优质护理用于重症结核合并糖尿病的临床护理效果分析. 糖尿病新世界, 2018, 21(21): 131-132.
- 35. 陈娟, 毛毅, 陈洪德. 30例危重症肺结核孕产妇的临床特征及预后分析. 中国防痨杂志, 2020, 42(6): 638-640.
- 36. 刘燕侠. 肺结核合并肝性脑病34例护理体会. 中国实用神经疾病杂志, 2015, 18(13): 122.
- 37. 张亚敬, 姜影, 孙浩, 等. 154例老年肺结核患者的发现与治疗转归情况分析. 结核与肺部疾病杂志, 2023, 4(1): 48-53.
- 38. 朱丽雅. 重症肺结核合并呼吸衰竭的护理. 中国基层医药, 2013, 20(2): 296-297.
- 39. 谢朝云, 覃家露, 熊芸, 等. 重症肺结核患者死亡危险因素分析. 人民军医, 2018, 61(1): 30-33, 37.
- 40. 冀小波, 毛敏杰, 徐节坤, 等. 重症肺结核合并真菌感染患者的临床特征及发病危险因素分析. 浙江医学, 2021, 43(18): 2013-2016, 2019.
- 41. 中华医学会结核病学分会重症专业委员会. 结核病营养治疗专家共识. 中华结核和呼吸杂志, 2020, 43(1): 17-26.
- 42. 张楠, 李琦, 潘丽萍, 等. 结核重症监护室真菌感染的危险因素分析. 中国医药导报, 2019, 16(1): 74-76, 81.
- 43. 王红岩, 张昕. 结核重症监护室呼吸机相关性肺炎感染的危险因素分析. 中国医药指南, 2020, 18(6): 108-109.
- 44. 王红岩, 张昕. 重症肺结核合并呼吸衰竭的临床特征分析. 中国医药指南, 2020, 18(16): 130-131.
- 45. 万青梅. 重症肺结核合并呼吸衰竭患者的临床护理方法以及效果评价. 医学美学美容(中旬刊), 2014, 23(8): 366.
- 46. 疏欣杨, 唐亮, 孙兵. 呼吸重症监护病房中以呼吸衰竭为突出表现的肺结核临床特点. 中日友好医院学报, 2014, 28(3): 139-142, 封2.
- 47. 石丽彩, 杨桂梅. 重症肺结核合并呼吸衰竭患者的护理. 临床合理用药杂志, 2012, 5(29): 166.
- 48. 马增光, 李志军, 陈杰勇. 重症肺结核79例临床分析. 临床合理用药杂志, 2014, 7(25): 39.
- 49. 李先锋. 青年重症肺结核60例观察与治疗. 医药前沿, 2014, (8): 115-116.
- 50. 李红. 重症肺结核合并呼吸衰竭临床分析. 中国卫生标准管理, 2015, 6(12): 132-133.
- 51. 李海涛, 郭晓新. 初治重症肺结核发现延迟相关因素分析. 河南预防医学杂志, 2012, 23(4): 275-276.
- 52. 龚惠莉. 60例重症肺结核合并呼吸衰竭临床分析. 现代预防医学, 2012, 39(1): 248-249.
- 53. 刘岩, 丁龙. 30例重症肺结核回顾性影像分析. 健康必读旬刊, 2013, 12(11): 101.
- 54. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med, 1995, 23(10): 1638-1652.
- 55. 中华医学会结核病学分会. 肺结核诊断和治疗指南. 中国实用乡村医生杂志, 2013, 20(2): 7-11.
- 56. Telisinghe L, Fielding KL, Malden JL, et al. High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PLoS One, 2014, 9(1): e87262.
- 57. Nguyen TBP, Nguyen TA, Luu BK, et al. A comparison of digital chest radiography and Xpert® MTB/RIF in active case finding for tuberculosis. Int J Tuberc Lung Dis, 2020, 24(9): 934-940.
- 58. 中华医学会放射学分会传染病放射学专业委员会. 肺结核影像学及分级诊断专家共识. 新发传染病电子杂志, 2018, 3(2): 118-127.
- 59. 刘长春, 古海尔, 常银勇, 等. 重症肺结核CT影像分析. 临床肺科杂志, 2007, 12(12): 1302-1304.
- 60. 陈影. 老年肺结核临床分析. 中国实用医药, 2015, (15): 61-62.
- 61. 周伟剑. 艾滋病患者合并重症肺结核的X线表现的探讨. 现代医用影像学, 2015, 24(6): 902-904.
- 62. 李宁, 王晓静, 冯光, 等. 高能量营养乳剂的肠内营养对重症肺结核机械通气患者的临床疗效. 临床肺科杂志, 2013, 18(5): 780-782.
- 63. Shaarawy H, El-Sayed Mohamed E. Assessment of the prevalence of pulmonary embolism in patients with severe pulmonary tuberculosis. Egypt J Chest Dis Tuberc, 2018, 67(1): 62-67.
- 64. 中华人民共和国国家卫生和计划生育委员会. 结核病分类(WS196—2017). 新发传染病电子杂志, 2018, 3(3): 191-192.
- 65. Pai M, Schito M. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis, 2015, 211(Suppl 2): S21-S28.
- 66. 《中国防痨杂志》编辑委员会, 中国医疗保健国际交流促进会结核病防治分会基础学组和临床学组. 结核分枝杆菌耐药性检测专家共识. 中国防痨杂志, 2019, 41(2): 129-137.
- 67. 中华医学会结核病学分会临床检验专业委员会. 结核病病原学分子诊断专家共识. 中华结核和呼吸杂志, 2018, 41(9): 688-695.
- 68. 刘一典. 复治肺结核病诊断和治疗专家共识. 中国防痨杂志, 2021, 43(12): 1226-1238.
- 69. Fusani L, Tersigni C, Chiappini E, et al. Old biomarkers in tuberculosis management: are they still useful. A systematic review. Expert Rev Anti Infect Ther, 2021, 19(10): 1191-1203.
- 70. Pierce R, Bigham MT, Giuliano JS. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children. Curr Opin Pediatr, 2014, 26(3): 292-298.
- 71. Kamat IS, Ramachandran V, Eswaran H, et al. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis, 2020, 70(3): 538-542.
- 72. Martin-Loeches I, Torres A, Nagavci B, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J, 2023, 61(4): 2200735.
- 73. Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med, 2008, 177(5): 498-505.
- 74. 李成行, 李月翠. 检测内毒素与C反应蛋白在诊断肺结核合并革兰阴性菌感染中的意义. 中国防痨杂志, 2013, 35(9): 702-705.
- 75. 万学红, 卢雪峰. 诊断学(第9版). 北京: 人民卫生出版社, 2018: 409-442.
- 76. Jones BE, Oo MM, Taikwel EK, et al. CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis, 1997, 24(5): 988-991.
- 77. 俞朝贤, 李德宪, 王娟, 等. 结核重症监护室患者外周血CD4+T淋巴细胞的检测与临床意义. 现代医院, 2019, 19(7): 1084-1086.
- 78. 汪彩红, 邱君克, 黄晓庆, 等. 重症肺结核患者外周血T细胞亚群在预后不良患者中的表达及临床意义. 中华医院感染学杂志, 2020, 30(9): 1327-1330.
- 79. 卫芳征. 外周血T细胞亚群和红细胞免疫功能与重症肺结核患者不良预后的相关性. 临床肺科杂志, 2018, 23(9): 1561-1565.
- 80. 黄健, 李明瑛, 牛文一, 等. 外周血Blimp1、IFN-γ、IL-10水平与重症肺结核的相关性分析. 分子诊断与治疗杂志, 2020, 12(12): 1745-1748.
- 81. 章敏. 外周血IFN-γ、IL-10水平及红细胞免疫功能对重症肺结核患者死亡预后的预测价值. 标记免疫分析与临床, 2020, 27(7): 1161-1165.
- 82. Kho ME, McDonald E, Stratford PW, et al. Interrater reliability of APACHE Ⅱ scores for medical surgical intensive care patients: a prospect blinded study. Am J Crit Care, 2007, 16: 378-380.
- 83. Lambden S, Laterre PF, Levy MM, et al. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care, 2019, 23(1): 374.
- 84. 王超, 苏强, 张淑文, 等. 多器官功能障碍综合征病情严重度评分系统. 中国医学科学院学报, 2007, 29(4): 497-500.
- 85. Wang D, Willis DR, Yih Y. The pneumonia severity index: assessment and comparison to popular machine learning classifiers. Int J Med Inform, 2022, 163: 104778.
- 86. 李宁, 王晓静, 冯光, 等. 重症肺结核合并COPD患者机械通气死亡预后因素分析. 临床肺科杂志, 2013, 18(4): 711-712.
- 87. Tatar D, Senol G, Kirakli C, et al. Contributing factors to mortality rates of pulmonary tuberculosis in intensive care units. J Chin Med Assoc, 2018, 81(7): 605-610.
- 88. Galvin J, Tiberi S, Akkerman O, et al. Pulmonary tuberculosis in intensive care setting, with a focus on the use of severity scores, a multinational collaborative systematic review. Pulmonology, 2022, 28(4): 297-309.
- 89. Rollas K, Kara A, Ortaç Ersoy NE, et al. Acute tuberculosis in the intensive care unit. Turk J Med Sci, 2015, 45(4): 882-887.
- 90. 张如云, 张静, 雷轩. 血清白蛋白、SOFA评分及APACHEⅡ评分对重症肺结核患者预后的评估价值. 临床肺科杂志, 2023, 28(3): 399-401,411.
- 91. Kim S, Kim H, Kim WJ, et al. Mortality and predictors in pulmonary tuberculosis with respiratory failure requiring mechanical ventilation. Int J Tuberc Lung Dis, 2016, 20(4): 524-529.
- 92. Cegielski JP, Arab L, Cornoni-Huntley J. Nutritional risk factors for tuberculosis among adults in the United States, 1971-1992. Am J Epidemiol, 2012, 176(5): 409-422.
- 93. WHO. WHO guidelines approved by the guidelines review committee. 2013.
- 94. Mueller C, Compher C, Ellen DM, et al. A. S. P. E. N. clinical guidelines: nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr, 2011, 35(1): 16-24.
- 95. Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr, 2003, 22(3): 321-336.
- 96. Heyland DK, Dhaliwal R, Jiang X, et al. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care, 2011, 15(6): R268.
- 97. 章志俊, 谭守勇. 营养风险筛查在结核病治疗中应用. 中国防痨杂志, 2015, 37(9): 971-974.
- 98. 营养风险及营养支持调查协作组, 蒋朱明, 陈伟, 等. 中国东、中、西部大城市三甲医院营养不良(不足)、营养风险发生率及营养支持应用状况调查. 中国临床营养杂志, 2008, 16(6): 335-337.
- 99. 顾良军, 詹斯·康卓普, 雷米·梅耶, 等. 营养风险筛查2002改善临床结局. 中华临床营养杂志, 2013, 21(3): 133-139.
- 100. Felder S, Lechtenboehmer C, Bally M, et al. Association of nutritional risk and adverse medical outcomes across different medical inpatient populations. Nutrition, 2015, 31(11-12): 1385-1393.
- 101. Mukhopadhyay A, Henry J, Ong V, et al. Association of modified NUTRIC score with 28-day mortality in critically ill patients. Clin Nutr, 2017, 36(4): 1143-1148.
- 102. Canales C, Elsayes A, Yeh DD, et al. Nutrition risk in critically ill versus the nutritional risk screening 2002: are they comparable for assessing risk of malnutrition in critically ill patients. JPEN J Parenter Enteral Nutr, 2019, 43(1): 81-87.
- 103. Heyland DK, Dhaliwal R, Wang M, et al. The prevalence of iatrogenic underfeeding in the nutritionally 'at-risk' critically ill patient: results of an international, multicenter, prospective study. Clin Nutr, 2015, 34(4): 659-666.
- 104. 陈志, 梁建琴. 结核病重症患者营养评估及营养支持治疗专家共识. 中国防痨杂志, 2022, 44(5): 421-432.